The University of Chicago Header Logo

Mitchell C. Posner

Concepts (881)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Esophageal Neoplasms
35
2020
332
5.130
Why?
Adenocarcinoma
45
2021
1194
4.190
Why?
Stomach Neoplasms
21
2021
281
3.770
Why?
Esophagectomy
15
2019
92
2.780
Why?
Liver Neoplasms
24
2023
756
2.460
Why?
Pancreatic Neoplasms
22
2019
669
2.340
Why?
Antineoplastic Combined Chemotherapy Protocols
22
2023
2563
2.210
Why?
Surgical Oncology
4
2023
27
2.080
Why?
Hepatectomy
11
2014
170
2.050
Why?
Colorectal Neoplasms
20
2023
981
1.810
Why?
Neoadjuvant Therapy
12
2018
374
1.720
Why?
Lymph Node Excision
9
2016
220
1.680
Why?
Pancreaticoduodenectomy
9
2019
83
1.600
Why?
Gastrectomy
10
2021
69
1.470
Why?
Carcinoma, Squamous Cell
16
2017
1096
1.270
Why?
General Surgery
5
2016
235
1.250
Why?
Medical Oncology
5
2023
383
1.100
Why?
Combined Modality Therapy
32
2019
1719
1.090
Why?
Head and Neck Neoplasms
9
2019
1063
1.040
Why?
Humans
196
2024
89222
1.040
Why?
Chemotherapy, Adjuvant
13
2017
487
0.970
Why?
Genetic Therapy
13
2008
370
0.950
Why?
Fellowships and Scholarships
6
2020
122
0.870
Why?
Human papillomavirus 16
2
2014
38
0.850
Why?
Esophagogastric Junction
2
2019
34
0.840
Why?
Carcinoma
6
2014
443
0.820
Why?
Middle Aged
78
2024
25929
0.760
Why?
MicroRNAs
8
2023
551
0.750
Why?
Neoplasms
19
2019
3037
0.750
Why?
Tumor Necrosis Factor-alpha
12
2012
699
0.740
Why?
Male
103
2024
42347
0.730
Why?
Laparoscopy
8
2020
771
0.720
Why?
Aged
69
2020
19128
0.720
Why?
Cholangiocarcinoma
3
2014
76
0.720
Why?
Survival Rate
19
2019
1900
0.710
Why?
Neoplasm Staging
23
2019
2011
0.700
Why?
Female
107
2024
46118
0.700
Why?
Rectal Neoplasms
4
2019
127
0.680
Why?
Prognosis
21
2022
3779
0.680
Why?
Treatment Outcome
36
2020
8227
0.660
Why?
Randomized Controlled Trials as Topic
5
2017
835
0.650
Why?
Metastasectomy
2
2019
9
0.640
Why?
Neoplasm Metastasis
12
2020
1108
0.640
Why?
Glucuronosyltransferase
1
2020
186
0.640
Why?
Antineoplastic Agents
17
2020
2412
0.600
Why?
Gene Expression Regulation, Neoplastic
11
2018
1265
0.590
Why?
Specialties, Surgical
6
2020
65
0.590
Why?
Awards and Prizes
2
2013
37
0.550
Why?
Fluorouracil
12
2023
561
0.540
Why?
Bile Duct Neoplasms
2
2014
90
0.540
Why?
Postoperative Complications
9
2024
2280
0.540
Why?
Surgical Procedures, Operative
7
2024
206
0.530
Why?
Education, Medical, Graduate
6
2018
393
0.530
Why?
Gastrointestinal Stromal Tumors
3
2012
23
0.530
Why?
Chemoradiotherapy, Adjuvant
1
2016
35
0.530
Why?
Follow-Up Studies
18
2019
3661
0.520
Why?
Lymph Nodes
3
2016
548
0.520
Why?
Immediate-Early Proteins
5
2004
165
0.510
Why?
Specialization
1
2015
65
0.500
Why?
Accreditation
1
2015
62
0.500
Why?
Digestive System Surgical Procedures
5
2019
126
0.500
Why?
Certification
1
2015
61
0.500
Why?
Pneumonia, Viral
4
2020
319
0.490
Why?
Coronavirus Infections
4
2020
304
0.490
Why?
Clinical Competence
8
2018
782
0.480
Why?
Comparative Effectiveness Research
1
2015
53
0.470
Why?
Carcinoma, Hepatocellular
3
2004
392
0.470
Why?
Pancreatectomy
8
2019
158
0.470
Why?
Neoplasm Recurrence, Local
14
2019
1365
0.470
Why?
Aged, 80 and over
21
2020
6799
0.450
Why?
Adult
52
2024
26559
0.450
Why?
Clinical Trials as Topic
8
2020
1151
0.440
Why?
Gastrointestinal Neoplasms
3
2022
111
0.440
Why?
Thoracotomy
2
2010
64
0.420
Why?
Societies, Medical
4
2019
570
0.410
Why?
Pandemics
5
2020
771
0.400
Why?
Biomarkers, Tumor
5
2022
1548
0.400
Why?
Medical Records Systems, Computerized
2
2011
40
0.400
Why?
Sarcoma
2
2012
220
0.390
Why?
Papillomavirus E7 Proteins
1
2011
31
0.390
Why?
Prospective Studies
15
2019
4281
0.390
Why?
Oncogene Proteins, Viral
1
2011
34
0.390
Why?
Disease Models, Animal
9
2017
2363
0.390
Why?
Liver Transplantation
5
2016
1177
0.380
Why?
Xenograft Model Antitumor Assays
11
2018
470
0.380
Why?
Forms and Records Control
1
2011
16
0.380
Why?
Papillomavirus Infections
1
2014
261
0.370
Why?
Barrett Esophagus
6
2014
93
0.370
Why?
DNA-Binding Proteins
7
2005
1241
0.350
Why?
Cancer Vaccines
2
2011
160
0.350
Why?
Attitude of Health Personnel
1
2015
643
0.350
Why?
Betacoronavirus
4
2020
261
0.350
Why?
Proteome
1
2011
132
0.350
Why?
Piperazines
3
2012
283
0.350
Why?
Radiotherapy
7
2017
331
0.350
Why?
Antibodies, Viral
2
2011
309
0.340
Why?
Mice, Nude
14
2020
814
0.340
Why?
Oropharyngeal Neoplasms
1
2011
132
0.330
Why?
Pyrimidines
3
2012
373
0.330
Why?
Promoter Regions, Genetic
9
2006
956
0.330
Why?
Cisplatin
13
2010
618
0.310
Why?
Survival Analysis
12
2017
1534
0.310
Why?
Transcription Factors
7
2005
1652
0.300
Why?
Deoxycytidine
3
2019
238
0.300
Why?
Carcinoembryonic Antigen
1
2007
40
0.300
Why?
Animals
44
2020
27338
0.300
Why?
Repressor Proteins
1
2011
423
0.300
Why?
Glycolipids
1
2007
29
0.300
Why?
Immunotherapy
3
2016
678
0.300
Why?
Postoperative Care
5
2017
231
0.300
Why?
Carcinoma, Pancreatic Ductal
2
2019
112
0.290
Why?
Healthcare Disparities
2
2024
413
0.290
Why?
Chemoradiotherapy
5
2018
309
0.290
Why?
Transcription, Genetic
6
2009
1157
0.290
Why?
Lung Neoplasms
9
2019
2357
0.290
Why?
Chromosomes, Human, Pair 14
2
2018
49
0.280
Why?
Induction Chemotherapy
2
2018
152
0.280
Why?
Disease-Free Survival
8
2019
1214
0.280
Why?
Retrospective Studies
18
2023
9034
0.280
Why?
Rats, Inbred Strains
1
2006
312
0.270
Why?
Glycoproteins
1
2007
234
0.270
Why?
Organoplatinum Compounds
3
2017
97
0.270
Why?
Interpersonal Relations
1
2007
174
0.270
Why?
Killer Cells, Natural
2
1999
275
0.270
Why?
Lymphatic Metastasis
6
2014
502
0.270
Why?
Consensus Development Conferences as Topic
2
2016
27
0.270
Why?
Time Factors
14
2017
5336
0.260
Why?
Patient Selection
4
2020
684
0.260
Why?
Hospitals, Low-Volume
2
2016
18
0.250
Why?
Islets of Langerhans Transplantation
2
2019
241
0.250
Why?
Apoptosis
8
2018
1717
0.250
Why?
Tumor Cells, Cultured
11
2018
1057
0.250
Why?
Leucovorin
4
2020
224
0.240
Why?
HIV Envelope Protein gp120
8
2000
19
0.240
Why?
Genetic Vectors
8
2012
446
0.240
Why?
Patient Dropouts
1
2004
30
0.240
Why?
Fibromatosis, Aggressive
1
2024
11
0.230
Why?
Herpesvirus 1, Human
4
2007
244
0.230
Why?
Models, Animal
2
2003
276
0.230
Why?
Neoplasm Transplantation
9
2016
397
0.230
Why?
Gastroenterology
2
2016
144
0.230
Why?
Mice
24
2020
11743
0.230
Why?
Cell Line, Tumor
15
2016
2553
0.220
Why?
Quality Indicators, Health Care
2
2016
146
0.220
Why?
Waiting Lists
1
2004
183
0.220
Why?
Laparotomy
4
2015
67
0.220
Why?
Mucin-1
1
2003
45
0.220
Why?
Oncolytic Virotherapy
3
2007
42
0.210
Why?
Stromal Cells
1
2003
151
0.210
Why?
Adenoviridae
7
2007
349
0.210
Why?
Radiotherapy, Adjuvant
3
2010
296
0.210
Why?
Internship and Residency
4
2018
1043
0.210
Why?
Peptide Fragments
2
2003
463
0.210
Why?
Endoscopy
3
2014
348
0.200
Why?
Transplantation, Heterotopic
1
2002
46
0.200
Why?
Early Growth Response Protein 1
8
2007
56
0.200
Why?
Abdominal Neoplasms
1
2002
39
0.200
Why?
Clinical Trials, Phase III as Topic
3
2018
175
0.200
Why?
Infection Control
2
2020
120
0.200
Why?
Antibodies, Monoclonal, Humanized
2
2020
968
0.200
Why?
Genes, p53
3
2001
109
0.200
Why?
Esophagoscopy
2
2014
90
0.200
Why?
Fibrosis
1
2003
234
0.200
Why?
Melanoma
2
1996
467
0.200
Why?
HIV-1
7
2000
166
0.190
Why?
Genotype
4
2020
1848
0.190
Why?
User-Computer Interface
2
2020
187
0.190
Why?
Biological Products
1
2024
155
0.190
Why?
Biopsy, Needle
6
2010
233
0.190
Why?
Circulating Tumor DNA
1
2022
47
0.190
Why?
Mouth Neoplasms
3
2015
198
0.190
Why?
Melanoma, Experimental
3
2011
104
0.190
Why?
Colonic Neoplasms
4
2003
573
0.190
Why?
Drug Resistance, Neoplasm
3
2018
617
0.180
Why?
Acetophenones
1
2020
27
0.180
Why?
Kidney Transplantation
2
2011
850
0.180
Why?
Cell-Free Nucleic Acids
1
2022
83
0.180
Why?
Tomography, X-Ray Computed
8
2019
2659
0.180
Why?
Biliary Tract Neoplasms
1
2000
33
0.180
Why?
Vaccination
2
2016
274
0.180
Why?
Recurrence
2
2014
1143
0.180
Why?
Breast Neoplasms
7
2015
3003
0.180
Why?
Imatinib Mesylate
3
2012
127
0.180
Why?
Adoptive Transfer
2
1999
169
0.180
Why?
Transplantation Tolerance
1
2002
138
0.180
Why?
Neoplasms, Experimental
4
2016
269
0.180
Why?
Actomyosin
1
2020
46
0.180
Why?
United States
12
2019
6975
0.170
Why?
Positron-Emission Tomography
2
2020
336
0.170
Why?
Pneumonectomy
1
2002
206
0.170
Why?
Rats
10
2007
4041
0.170
Why?
Surgery Department, Hospital
1
2020
44
0.170
Why?
Personnel Selection
1
2020
60
0.170
Why?
HCT116 Cells
5
2020
155
0.170
Why?
Hypothyroidism
1
2001
241
0.170
Why?
History, 20th Century
2
2013
310
0.170
Why?
Biliary Tract Surgical Procedures
2
2016
11
0.170
Why?
Disease Transmission, Infectious
1
2020
58
0.170
Why?
Erlotinib Hydrochloride
1
2019
90
0.170
Why?
Benzamides
3
2012
237
0.170
Why?
Health Resources
1
2020
81
0.170
Why?
Mutation
7
2018
4141
0.170
Why?
Income
1
2019
83
0.170
Why?
Guidelines as Topic
2
2018
160
0.160
Why?
Internet
3
2020
318
0.160
Why?
Cytoskeleton
1
2020
195
0.160
Why?
Interviews as Topic
1
2020
337
0.160
Why?
Colectomy
1
2000
172
0.160
Why?
Cytokines
2
2002
802
0.160
Why?
Liver Diseases
1
2001
242
0.160
Why?
B7-H1 Antigen
2
2018
274
0.160
Why?
Immunohistochemistry
7
2012
1799
0.160
Why?
Palliative Medicine
1
2018
11
0.160
Why?
Minimally Invasive Surgical Procedures
3
2012
253
0.160
Why?
Hospitals
3
2019
299
0.160
Why?
Antineoplastic Agents, Immunological
1
2020
195
0.160
Why?
Manuscripts as Topic
1
2018
4
0.150
Why?
Risk Assessment
5
2014
2301
0.150
Why?
Carcinoma, Adenosquamous
1
1998
12
0.150
Why?
Precancerous Conditions
2
2009
200
0.150
Why?
Gene Amplification
1
2018
134
0.150
Why?
Writing
1
2018
29
0.150
Why?
Janus Kinase 2
1
2018
60
0.150
Why?
Residence Characteristics
1
2019
202
0.150
Why?
Perioperative Care
1
2019
169
0.150
Why?
Parenteral Nutrition
1
1998
63
0.150
Why?
Pyrrolidines
1
2018
59
0.150
Why?
Adrenal Gland Neoplasms
2
2003
81
0.150
Why?
Transplantation, Heterologous
4
2003
370
0.140
Why?
Radiation, Ionizing
6
2011
121
0.140
Why?
Thinness
1
2017
44
0.140
Why?
Nitric Oxide Synthase
1
1997
126
0.140
Why?
Publishing
1
2018
90
0.140
Why?
Chicago
5
2020
1424
0.140
Why?
Clinical Trials, Phase II as Topic
1
2017
172
0.140
Why?
Journal Impact Factor
1
2016
15
0.140
Why?
Interleukin-2
1
1997
251
0.140
Why?
DNA
5
2012
1307
0.140
Why?
Nanostructures
1
2017
79
0.140
Why?
Hospitals, High-Volume
1
2016
36
0.130
Why?
Benchmarking
1
2016
79
0.130
Why?
Chemotherapy, Cancer, Regional Perfusion
1
1995
18
0.130
Why?
Sulfonamides
1
2018
318
0.130
Why?
Chemokine CXCL10
1
2015
23
0.130
Why?
Tissue Preservation
1
2015
14
0.130
Why?
Surgeons
1
2019
247
0.130
Why?
Disease Progression
5
2012
1488
0.130
Why?
Hepatitis C
1
1997
172
0.120
Why?
Viral Proteins
2
2007
301
0.120
Why?
Protein Kinase Inhibitors
2
2018
604
0.120
Why?
Pancreatic Fistula
1
2015
17
0.120
Why?
Hyperthermia, Induced
1
1995
73
0.120
Why?
DNA Methylation
2
2018
657
0.120
Why?
Octreotide
1
2015
23
0.120
Why?
Antibodies, Monoclonal
6
2014
1410
0.120
Why?
Quality Improvement
2
2016
447
0.120
Why?
Diagnostic Imaging
3
2015
479
0.120
Why?
Drug Therapy
1
2015
70
0.120
Why?
Skin Neoplasms
2
2019
579
0.120
Why?
Pancreatitis, Chronic
1
2015
54
0.120
Why?
Signal Transduction
5
2024
3376
0.120
Why?
Teaching
2
2013
147
0.120
Why?
Self Care
1
2015
164
0.120
Why?
Decision Making
1
2020
665
0.120
Why?
Dissent and Disputes
1
2014
29
0.120
Why?
Pursuit, Smooth
1
1994
32
0.120
Why?
Universities
1
2015
146
0.120
Why?
Graft Rejection
3
2011
1069
0.120
Why?
Tumor Suppressor Protein p53
5
2007
414
0.120
Why?
Periodicals as Topic
1
2016
168
0.120
Why?
Cholangitis
2
2012
19
0.120
Why?
Pediatrics
1
2018
352
0.110
Why?
Cohort Studies
6
2017
2866
0.110
Why?
CD4 Antigens
5
2000
83
0.110
Why?
Cetuximab
1
2014
117
0.110
Why?
Referral and Consultation
1
2016
341
0.110
Why?
Body Mass Index
1
2017
773
0.110
Why?
Registries
2
2015
781
0.110
Why?
Data Collection
1
2015
375
0.110
Why?
Critical Care
1
2016
380
0.110
Why?
Peritoneal Lavage
1
2013
12
0.110
Why?
Biomedical Research
1
2018
398
0.110
Why?
SEER Program
1
2014
197
0.110
Why?
Carcinoma, Non-Small-Cell Lung
3
2018
1116
0.110
Why?
Precision Medicine
1
2017
410
0.110
Why?
Preoperative Care
3
2017
396
0.110
Why?
Incidence
6
2014
1593
0.110
Why?
Mastectomy, Segmental
1
1994
101
0.110
Why?
Length of Stay
5
2017
733
0.110
Why?
Pilot Projects
4
2024
868
0.110
Why?
Enzyme-Linked Immunosorbent Assay
2
2011
374
0.110
Why?
History, 21st Century
1
2013
179
0.110
Why?
Program Evaluation
3
2020
307
0.110
Why?
Cues
1
1994
174
0.110
Why?
Receptor, EphB4
1
2012
24
0.110
Why?
Interferon-alpha
3
2010
226
0.100
Why?
Geriatric Assessment
1
2014
182
0.100
Why?
Lung
5
2012
1259
0.100
Why?
Sequence Deletion
3
2007
205
0.100
Why?
Urinary Bladder Neoplasms
1
2016
401
0.100
Why?
Portraits as Topic
1
2012
6
0.100
Why?
Heterografts
3
2018
102
0.100
Why?
Genomics
1
2017
762
0.100
Why?
Carcinoma, Lobular
1
2012
81
0.100
Why?
Cadherins
1
2012
163
0.100
Why?
Leadership
1
2013
138
0.100
Why?
Carcinoma in Situ
1
1992
53
0.100
Why?
Islets of Langerhans
1
2015
548
0.100
Why?
Adolescent
11
2017
9247
0.100
Why?
Patient Care Team
1
2014
283
0.100
Why?
Hemangioma, Cavernous
1
1992
69
0.100
Why?
CD8-Positive T-Lymphocytes
2
2016
595
0.100
Why?
Databases, Factual
4
2019
852
0.090
Why?
Intraoperative Period
1
2011
90
0.090
Why?
Faculty, Medical
1
2013
185
0.090
Why?
Urine
1
2011
89
0.090
Why?
Maximum Tolerated Dose
1
2012
272
0.090
Why?
Capecitabine
1
2011
98
0.090
Why?
Remission Induction
4
2001
740
0.090
Why?
Research Design
2
2013
598
0.090
Why?
Carcinoma, Intraductal, Noninfiltrating
1
1992
115
0.090
Why?
MAP Kinase Kinase Kinases
2
2007
42
0.090
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2011
77
0.090
Why?
Oxidoreductases
1
2011
112
0.090
Why?
Educational Measurement
2
2009
231
0.090
Why?
Bile Ducts, Extrahepatic
1
2010
11
0.090
Why?
Virus Replication
4
2007
321
0.090
Why?
Benzimidazoles
1
2011
111
0.090
Why?
Obesity
1
2017
970
0.090
Why?
Oligonucleotide Array Sequence Analysis
4
2011
695
0.090
Why?
Drug Administration Schedule
4
2017
895
0.090
Why?
Neoplasm, Residual
2
2015
181
0.090
Why?
Cholestasis
1
1990
45
0.090
Why?
Lymphocytes, Tumor-Infiltrating
1
2011
131
0.090
Why?
Immunologic Memory
1
2011
163
0.090
Why?
HIV Antibodies
3
1995
26
0.090
Why?
DNA Damage
3
2011
371
0.080
Why?
Digestive System Neoplasms
1
2009
21
0.080
Why?
Triage
2
2020
111
0.080
Why?
STAT1 Transcription Factor
1
2009
53
0.080
Why?
X-Ray Therapy
1
2008
6
0.080
Why?
Fibroma
1
1989
33
0.080
Why?
Feedback
1
2009
134
0.080
Why?
Neuroendocrine Tumors
1
2011
118
0.080
Why?
Transforming Growth Factor beta
1
2011
321
0.080
Why?
Membrane Glycoproteins
1
2011
432
0.080
Why?
Treatment Failure
3
2012
287
0.080
Why?
Genetic Testing
1
2012
537
0.080
Why?
Radiation-Sensitizing Agents
1
2008
97
0.080
Why?
Thoracoscopy
3
1998
23
0.080
Why?
Enzyme Inhibitors
1
2011
645
0.080
Why?
Stilbenes
1
2007
25
0.080
Why?
Interleukin-4
2
2002
130
0.080
Why?
Lipid Droplets
1
2007
16
0.080
Why?
Antibodies, Anti-Idiotypic
1
2007
44
0.080
Why?
Doxorubicin
2
2009
298
0.080
Why?
Epitopes
5
2000
255
0.070
Why?
Child
9
2018
7158
0.070
Why?
Mice, Inbred C57BL
5
2016
3211
0.070
Why?
Proto-Oncogene Proteins c-kit
2
2007
80
0.070
Why?
Gene Expression Profiling
4
2018
1429
0.070
Why?
Adenoviruses, Human
2
2012
41
0.070
Why?
Necrosis
2
2007
209
0.070
Why?
Hypercalcemia
1
2007
62
0.070
Why?
Ethics, Medical
1
2010
307
0.070
Why?
Kaplan-Meier Estimate
2
2021
860
0.070
Why?
Parathyroid Neoplasms
1
2007
57
0.070
Why?
Immunity, Cellular
1
2007
178
0.070
Why?
Common Bile Duct
2
1991
20
0.070
Why?
Blood Cells
1
2006
33
0.070
Why?
Veratrum Alkaloids
1
2006
10
0.070
Why?
Cell Movement
3
2020
783
0.070
Why?
Transplantation, Autologous
2
2019
343
0.070
Why?
Infusions, Intravenous
5
1995
434
0.070
Why?
Genetic Predisposition to Disease
2
2012
2338
0.070
Why?
Paclitaxel
2
2006
479
0.070
Why?
Luminescent Proteins
2
2004
144
0.070
Why?
eIF-2 Kinase
1
2006
48
0.070
Why?
Drug Synergism
3
2017
306
0.070
Why?
Gene Expression
4
2015
1310
0.070
Why?
Gallbladder
1
1985
31
0.060
Why?
Endothelium, Vascular
3
2004
433
0.060
Why?
Neutralization Tests
6
2001
80
0.060
Why?
Green Fluorescent Proteins
2
2004
309
0.060
Why?
Hedgehog Proteins
1
2006
100
0.060
Why?
Mitogen-Activated Protein Kinase Kinases
1
2006
102
0.060
Why?
Spleen
1
2006
432
0.060
Why?
p38 Mitogen-Activated Protein Kinases
1
2005
125
0.060
Why?
Rats, Inbred F344
3
1997
154
0.060
Why?
Congresses as Topic
2
2016
113
0.060
Why?
Mice, SCID
2
2016
261
0.060
Why?
Endothelial Cells
2
2008
459
0.060
Why?
Models, Biological
4
2006
1765
0.060
Why?
Polyethylene Glycols
2
2017
358
0.060
Why?
Glycine
1
2005
94
0.060
Why?
Transplantation, Homologous
2
2011
996
0.060
Why?
Ethiodized Oil
1
2004
1
0.060
Why?
Camptothecin
2
2017
193
0.060
Why?
Cyclophosphamide
1
2005
299
0.060
Why?
Cytotoxins
1
2004
16
0.060
Why?
NF-kappa B
1
2007
466
0.060
Why?
Chemoembolization, Therapeutic
1
2004
35
0.060
Why?
Adjuvants, Immunologic
1
2005
168
0.060
Why?
Reproducibility of Results
2
2011
2754
0.060
Why?
Transfection
6
2007
911
0.060
Why?
Logistic Models
2
2019
1212
0.060
Why?
Body Weight
3
2017
452
0.060
Why?
Antibiotics, Antineoplastic
1
2004
116
0.060
Why?
Vascular Endothelial Growth Factor A
3
2018
423
0.060
Why?
Neoplasms, Multiple Primary
2
1996
103
0.060
Why?
Internationality
2
2014
69
0.060
Why?
Behavior, Animal
1
2006
378
0.060
Why?
Needs Assessment
2
2015
157
0.060
Why?
Young Adult
4
2017
6301
0.060
Why?
HIV Seropositivity
2
1995
51
0.050
Why?
Cell Adhesion
2
2020
426
0.050
Why?
Staining and Labeling
1
2003
168
0.050
Why?
Mitosis
1
2003
152
0.050
Why?
Etoposide
4
2007
206
0.050
Why?
Liver Cirrhosis
1
2004
256
0.050
Why?
Erythropoietin
1
2003
88
0.050
Why?
Cell Transformation, Neoplastic
1
2005
447
0.050
Why?
Random Allocation
1
2003
327
0.050
Why?
Mortality
1
2003
149
0.050
Why?
External Fixators
2
1992
19
0.050
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2002
118
0.050
Why?
Rats, Inbred ACI
1
2002
25
0.050
Why?
Aortic Diseases
2
1994
102
0.050
Why?
Transplantation, Isogeneic
1
2002
39
0.050
Why?
Ethanol
1
2004
250
0.050
Why?
Diagnosis, Differential
2
2010
1596
0.050
Why?
Tumor Burden
2
2015
308
0.050
Why?
beta Catenin
1
2024
266
0.050
Why?
Catheter Ablation
1
2004
253
0.050
Why?
Endothelial Growth Factors
1
2002
55
0.050
Why?
Lymphokines
1
2002
76
0.050
Why?
Rats, Inbred Lew
1
2002
193
0.050
Why?
Prostatic Neoplasms
2
2011
1769
0.050
Why?
Risk Factors
4
2017
5490
0.050
Why?
Glioblastoma
1
2004
265
0.050
Why?
Analysis of Variance
2
2001
899
0.050
Why?
Drug Evaluation
2
1992
138
0.050
Why?
Guanine
1
2002
207
0.050
Why?
Up-Regulation
4
2005
727
0.050
Why?
Recombinant Proteins
2
2010
1012
0.050
Why?
Interleukin-10
1
2002
151
0.050
Why?
Focal Nodular Hyperplasia
1
2001
10
0.050
Why?
Coumarins
1
2000
13
0.050
Why?
Receptors, Chemokine
1
2000
31
0.050
Why?
Real-Time Polymerase Chain Reaction
2
2012
282
0.050
Why?
Thyrotropin
2
2001
289
0.050
Why?
Hamartoma
1
2001
34
0.050
Why?
Blood Loss, Surgical
1
2001
115
0.050
Why?
Hemangioma
1
2001
64
0.050
Why?
Cytoreduction Surgical Procedures
1
2021
76
0.050
Why?
Cell Proliferation
2
2018
1650
0.050
Why?
Health Services Accessibility
1
2024
427
0.050
Why?
Illinois
2
2014
477
0.040
Why?
Polysaccharides
1
2000
90
0.040
Why?
Organizational Innovation
1
2020
41
0.040
Why?
Biomarkers
3
2003
1764
0.040
Why?
Patient Readmission
2
2014
352
0.040
Why?
Phenotype
3
2015
2439
0.040
Why?
Mice, Transgenic
2
2016
1574
0.040
Why?
Cysts
1
2001
106
0.040
Why?
Efficiency, Organizational
1
2020
59
0.040
Why?
Spinal Nerve Roots
1
1999
17
0.040
Why?
Ampulla of Vater
1
2019
23
0.040
Why?
Peripheral Nervous System Neoplasms
1
1999
19
0.040
Why?
Odds Ratio
1
2001
683
0.040
Why?
Neurilemmoma
1
1999
34
0.040
Why?
Healthy Lifestyle
1
2019
8
0.040
Why?
Retroperitoneal Neoplasms
1
1999
44
0.040
Why?
Neoplasm Invasiveness
3
2005
576
0.040
Why?
Rats, Nude
1
1999
25
0.040
Why?
Genes, env
3
1993
8
0.040
Why?
DNA (Cytosine-5-)-Methyltransferase 1
1
2018
20
0.040
Why?
Pathology, Molecular
1
2019
34
0.040
Why?
Predictive Value of Tests
2
2014
1721
0.040
Why?
Cell Survival
3
2007
982
0.040
Why?
MCF-7 Cells
1
2018
114
0.040
Why?
Adenoma
1
2001
246
0.040
Why?
DNA (Cytosine-5-)-Methyltransferases
1
2018
60
0.040
Why?
Keratinocytes
1
1999
146
0.040
Why?
Primary Prevention
1
2019
82
0.040
Why?
Class II Phosphatidylinositol 3-Kinases
1
2018
9
0.040
Why?
Equivalence Trials as Topic
1
2018
6
0.040
Why?
Child, Preschool
4
2001
3724
0.040
Why?
Risk
1
2020
657
0.040
Why?
Training Support
1
2018
23
0.040
Why?
Interdisciplinary Studies
1
2018
20
0.040
Why?
Molecular Targeted Therapy
1
2020
285
0.040
Why?
Medical Staff, Hospital
2
2009
108
0.040
Why?
Feasibility Studies
3
2013
780
0.040
Why?
Mutagenesis, Site-Directed
3
1993
283
0.040
Why?
Laryngectomy
1
2018
26
0.040
Why?
Neoplasm Proteins
1
2002
540
0.040
Why?
Anorexia
2
2013
30
0.040
Why?
Nutrition Disorders
1
1998
15
0.040
Why?
Thoracic Neoplasms
1
1998
64
0.040
Why?
Gene Knockdown Techniques
1
2018
247
0.040
Why?
Azacitidine
1
2018
147
0.040
Why?
Perfusion
1
1999
235
0.040
Why?
Filgrastim
1
2017
57
0.040
Why?
Injections, Intralesional
2
2012
22
0.040
Why?
Pregnancy Complications
1
2001
345
0.040
Why?
Oxygen
1
2003
742
0.040
Why?
Receptor, Notch1
1
2018
94
0.040
Why?
Dihydroxyphenylalanine
1
2017
13
0.040
Why?
Point Mutation
1
1998
245
0.040
Why?
Dose-Response Relationship, Drug
4
2006
1940
0.040
Why?
HIV Envelope Protein gp41
2
1994
3
0.040
Why?
Reoperation
3
2014
598
0.040
Why?
RNA, Long Noncoding
1
2018
117
0.040
Why?
Enzyme Induction
1
1997
88
0.040
Why?
Actins
1
2020
458
0.040
Why?
Radiotherapy Dosage
1
1998
470
0.040
Why?
Cyclins
1
1997
83
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
1997
80
0.040
Why?
Algorithms
2
2006
1876
0.040
Why?
Carcinoma, Lewis Lung
2
2011
24
0.040
Why?
cdc25 Phosphatases
1
2016
19
0.040
Why?
Professional Autonomy
1
2016
41
0.040
Why?
Safety
2
2013
149
0.040
Why?
Drug Carriers
1
2017
82
0.030
Why?
Kidney Neoplasms
2
2002
638
0.030
Why?
Kidney
1
2002
1146
0.030
Why?
ErbB Receptors
1
1999
500
0.030
Why?
Overweight
1
2017
119
0.030
Why?
Chemokines
1
2016
74
0.030
Why?
Pancreaticojejunostomy
1
1995
1
0.030
Why?
Hepacivirus
1
1997
130
0.030
Why?
Pseudarthrosis
2
1992
5
0.030
Why?
Somatostatin
1
1995
53
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2005
887
0.030
Why?
Pancreatic Ducts
1
1995
28
0.030
Why?
Vero Cells
2
2006
102
0.030
Why?
Laryngeal Neoplasms
1
1996
89
0.030
Why?
Infant
2
2001
3152
0.030
Why?
North America
1
2016
184
0.030
Why?
Pregnancy
2
2001
3015
0.030
Why?
Receptors, CXCR3
1
2015
12
0.030
Why?
Cell Differentiation
2
2016
1521
0.030
Why?
Ipratropium
1
1995
18
0.030
Why?
Common Cold
1
1995
13
0.030
Why?
T-Lymphocytes
1
2002
1224
0.030
Why?
Luminescent Measurements
1
2015
62
0.030
Why?
Practice Guidelines as Topic
2
2014
1044
0.030
Why?
Leg
1
1995
140
0.030
Why?
Lost to Follow-Up
1
2015
15
0.030
Why?
Cholesterol
1
2017
358
0.030
Why?
Alprostadil
1
1994
25
0.030
Why?
Personnel, Hospital
1
2015
30
0.030
Why?
Clinical Coding
1
2015
24
0.030
Why?
Magnetic Resonance Imaging
3
2004
3444
0.030
Why?
Infectious Disease Transmission, Vertical
1
1995
46
0.030
Why?
Muromonab-CD3
1
1994
69
0.030
Why?
Graft Survival
2
1995
900
0.030
Why?
Parenteral Nutrition, Total
1
1994
41
0.030
Why?
Embolism, Cholesterol
1
1994
2
0.030
Why?
Age Factors
1
2019
1868
0.030
Why?
Quality Control
1
2015
117
0.030
Why?
Flow Cytometry
1
2016
691
0.030
Why?
Mice, Inbred NOD
1
2015
195
0.030
Why?
International Classification of Diseases
1
2015
69
0.030
Why?
Popliteal Artery
1
1994
28
0.030
Why?
Administration, Oral
2
1995
682
0.030
Why?
Acquired Immunodeficiency Syndrome
1
1995
80
0.030
Why?
Base Sequence
3
2011
2327
0.030
Why?
Blotting, Western
2
2007
794
0.030
Why?
Medical Records
1
2015
120
0.030
Why?
Robotic Surgical Procedures
1
2020
304
0.030
Why?
Relative Value Scales
1
2014
9
0.030
Why?
Enzyme Activation
2
2006
698
0.030
Why?
Femoral Artery
1
1994
83
0.030
Why?
Arteriosclerosis
1
1994
112
0.030
Why?
Fovea Centralis
1
1994
21
0.030
Why?
Salvage Therapy
1
1995
236
0.030
Why?
Fixation, Ocular
1
1994
48
0.030
Why?
Dumping Syndrome
1
2013
5
0.030
Why?
Avitaminosis
1
2013
5
0.030
Why?
Pancreas
1
1995
246
0.030
Why?
Caregivers
1
2015
159
0.030
Why?
Risk Adjustment
1
2014
38
0.030
Why?
Survivors
1
2015
233
0.030
Why?
Saccades
1
1994
69
0.030
Why?
Pregnancy Complications, Infectious
1
1995
117
0.030
Why?
Social Support
1
2015
209
0.030
Why?
Practice Patterns, Physicians'
1
2019
599
0.030
Why?
Chronic Disease
1
1997
948
0.030
Why?
Radiography, Interventional
1
1995
154
0.030
Why?
Frail Elderly
1
2014
82
0.030
Why?
Competency-Based Education
1
2013
36
0.030
Why?
Multivariate Analysis
1
2016
988
0.030
Why?
Solitary Pulmonary Nodule
1
1994
139
0.030
Why?
Cell Cycle
2
2006
509
0.030
Why?
Foot Deformities
1
1992
6
0.030
Why?
Bone Lengthening
1
1992
4
0.030
Why?
Aortic Aneurysm, Abdominal
1
1994
120
0.030
Why?
Radiography
2
1992
809
0.030
Why?
Hyperplasia
2
2009
152
0.030
Why?
Umbilical Veins
2
2004
46
0.030
Why?
Motion Perception
1
1994
106
0.030
Why?
Contracture
1
1992
18
0.030
Why?
Multigene Family
2
2005
203
0.030
Why?
Diarrhea
1
2013
182
0.030
Why?
Population Surveillance
1
2014
216
0.030
Why?
Imaging, Three-Dimensional
1
2016
596
0.030
Why?
Gastric Mucosa
1
2012
66
0.030
Why?
Extracellular Space
1
1992
92
0.030
Why?
Tissue Array Analysis
1
2012
127
0.030
Why?
DNA, Complementary
2
2004
392
0.030
Why?
Immunoblotting
1
2012
273
0.030
Why?
Schistosomiasis japonica
1
1991
1
0.030
Why?
Hand Deformities, Congenital
1
1991
15
0.030
Why?
Antibodies, Helminth
1
1991
10
0.030
Why?
Gastric Bypass
1
2013
110
0.020
Why?
Gene Dosage
1
2012
208
0.020
Why?
Mesenteric Vascular Occlusion
1
1991
18
0.020
Why?
Parotid Diseases
1
1991
5
0.020
Why?
Surgical Wound Infection
1
2014
201
0.020
Why?
Infarction
1
1991
27
0.020
Why?
Prevalence
2
2007
1243
0.020
Why?
Pancreatitis
1
2012
86
0.020
Why?
Neoplastic Cells, Circulating
1
1991
71
0.020
Why?
Cholestasis, Extrahepatic
1
1991
4
0.020
Why?
Thrombocytopenia
2
1990
187
0.020
Why?
Vaccines, DNA
1
2011
18
0.020
Why?
Perioperative Period
1
2011
25
0.020
Why?
Immunization, Secondary
1
2011
32
0.020
Why?
RNA, Messenger
1
1997
2012
0.020
Why?
DNA Repair
2
2004
362
0.020
Why?
Tamoxifen
1
1992
168
0.020
Why?
DNA Breaks, Double-Stranded
1
2011
66
0.020
Why?
National Cancer Institute (U.S.)
1
2011
73
0.020
Why?
Cluster Analysis
1
2011
371
0.020
Why?
Fibroblasts
1
1994
755
0.020
Why?
Cells, Cultured
3
2004
2880
0.020
Why?
Leukopenia
1
1990
66
0.020
Why?
Antigens, CD
1
2012
466
0.020
Why?
Hematemesis
1
2010
3
0.020
Why?
Drug Therapy, Combination
2
2011
784
0.020
Why?
Creatinine
1
2011
293
0.020
Why?
Family
1
2012
325
0.020
Why?
Databases, Genetic
1
2011
263
0.020
Why?
Antimetabolites, Antineoplastic
1
2012
244
0.020
Why?
Models, Statistical
1
2014
575
0.020
Why?
Cholangiopancreatography, Endoscopic Retrograde
1
2010
64
0.020
Why?
Multicenter Studies as Topic
1
2010
155
0.020
Why?
Glomerular Filtration Rate
1
2011
275
0.020
Why?
Alanine Transaminase
1
1990
71
0.020
Why?
Disease Management
1
2012
329
0.020
Why?
Education, Medical
1
2013
243
0.020
Why?
Reference Standards
1
2010
144
0.020
Why?
Aspartate Aminotransferases
1
1990
74
0.020
Why?
Surveys and Questionnaires
1
2018
2616
0.020
Why?
Taxoids
1
2010
130
0.020
Why?
Sepsis
1
2014
320
0.020
Why?
Bilirubin
1
1990
129
0.020
Why?
RNA Polymerase II
1
1990
57
0.020
Why?
Forecasting
1
2011
306
0.020
Why?
Depression
1
2013
504
0.020
Why?
Mastectomy
1
1992
245
0.020
Why?
Bile Duct Diseases
1
2009
22
0.020
Why?
Mucous Membrane
1
2009
83
0.020
Why?
Task Performance and Analysis
1
2009
87
0.020
Why?
Epithelial Cells
2
2005
688
0.020
Why?
Mammography
1
1992
471
0.020
Why?
Immunotherapy, Adoptive
1
2011
189
0.020
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2008
20
0.020
Why?
Statistics, Nonparametric
1
2009
306
0.020
Why?
Etanercept
1
2008
33
0.020
Why?
Nuclear Proteins
2
2004
726
0.020
Why?
Recombinant Fusion Proteins
2
2006
565
0.020
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2008
43
0.020
Why?
Binding Sites
3
2000
1117
0.020
Why?
Receptors, Tumor Necrosis Factor
1
2008
90
0.020
Why?
Probability
1
2009
353
0.020
Why?
HeLa Cells
2
2005
511
0.020
Why?
Stem Cells
1
2011
372
0.020
Why?
Sensitivity and Specificity
1
2013
2014
0.020
Why?
Metaplasia
1
2007
37
0.020
Why?
CD4-Positive T-Lymphocytes
1
2011
445
0.020
Why?
Cross-Sectional Studies
1
2013
1710
0.020
Why?
Oncolytic Viruses
1
2007
24
0.020
Why?
Cell Line
4
1993
2495
0.020
Why?
Acetylation
1
2007
132
0.020
Why?
Quinoxalines
1
2007
50
0.020
Why?
Sirtuins
1
2007
46
0.020
Why?
Luciferases
1
2007
128
0.020
Why?
Interferon-gamma
1
2009
451
0.020
Why?
Quality of Life
1
2015
1665
0.020
Why?
Mass Screening
1
1992
636
0.020
Why?
Genetic Engineering
1
2007
115
0.020
Why?
Cellular Senescence
1
2007
103
0.020
Why?
Imidazoles
1
2007
148
0.020
Why?
Parathyroidectomy
1
2007
77
0.020
Why?
Antineoplastic Protocols
1
2006
9
0.020
Why?
Academic Medical Centers
1
2009
385
0.020
Why?
Stomatitis
1
2006
30
0.020
Why?
Genes, Neoplasm
1
2006
37
0.020
Why?
Immunoglobulin G
1
2008
465
0.020
Why?
Endoscopy, Gastrointestinal
1
2007
157
0.020
Why?
Parathyroid Hormone
1
2007
217
0.020
Why?
Aging
1
2011
716
0.020
Why?
Gene Deletion
1
2007
342
0.020
Why?
Herpes Simplex
1
2007
203
0.020
Why?
Genes, MDR
1
2005
7
0.020
Why?
Quality of Health Care
1
2009
385
0.020
Why?
Tumor Necrosis Factors
1
2005
14
0.020
Why?
Wounds, Stab
1
1985
10
0.020
Why?
Genes, ras
1
2006
98
0.020
Why?
Emergency Service, Hospital
1
2010
521
0.020
Why?
Cholecystectomy
1
1985
21
0.020
Why?
Flavonoids
1
2006
87
0.020
Why?
Cornified Envelope Proline-Rich Proteins
1
2005
6
0.020
Why?
Cell Death
1
2006
262
0.020
Why?
GATA6 Transcription Factor
1
2005
13
0.020
Why?
Abdominal Injuries
1
1985
46
0.020
Why?
Injections, Intraperitoneal
1
2005
101
0.020
Why?
Palliative Care
1
2007
264
0.020
Why?
Gene Expression Regulation, Viral
1
2005
91
0.020
Why?
DNA, Viral
1
2005
262
0.020
Why?
MAP Kinase Signaling System
1
2005
197
0.020
Why?
Postoperative Period
1
2005
302
0.020
Why?
Mice, Inbred C3H
1
2005
371
0.020
Why?
Integrin alphaV
1
2004
4
0.010
Why?
Rabbits
1
2005
638
0.010
Why?
Infrared Rays
1
2004
17
0.010
Why?
DNA-Activated Protein Kinase
1
2004
16
0.010
Why?
Integrin alphaVbeta3
1
2004
17
0.010
Why?
Integrin beta1
1
2004
33
0.010
Why?
Mitogen-Activated Protein Kinase 1
1
2004
77
0.010
Why?
Wounds, Nonpenetrating
1
1985
111
0.010
Why?
Acetylcysteine
1
2004
70
0.010
Why?
Ataxia Telangiectasia Mutated Proteins
1
2004
55
0.010
Why?
Coculture Techniques
1
2004
173
0.010
Why?
Wounds, Gunshot
1
1985
92
0.010
Why?
Rad51 Recombinase
1
2004
80
0.010
Why?
Immunosuppressive Agents
1
2008
975
0.010
Why?
Clinical Chemistry Tests
1
2003
11
0.010
Why?
Phosphorylation
1
2005
1130
0.010
Why?
Pheochromocytoma
1
2003
49
0.010
Why?
Cell Division
1
2004
696
0.010
Why?
Hypoxia-Inducible Factor 1
1
2003
43
0.010
Why?
Calcium
1
2007
1174
0.010
Why?
CHO Cells
1
2002
187
0.010
Why?
Plasmids
1
2003
291
0.010
Why?
Tumor Suppressor Proteins
1
2004
290
0.010
Why?
Neovascularization, Pathologic
1
2004
364
0.010
Why?
Cell Hypoxia
1
2003
170
0.010
Why?
Vascular Endothelial Growth Factors
1
2002
56
0.010
Why?
Cathepsin L
1
2001
7
0.010
Why?
Recombination, Genetic
1
2004
444
0.010
Why?
Severity of Illness Index
1
2007
1838
0.010
Why?
Liver
2
2001
1206
0.010
Why?
Cathepsins
1
2001
21
0.010
Why?
Cell Line, Transformed
1
2002
155
0.010
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2003
155
0.010
Why?
Urokinase-Type Plasminogen Activator
1
2001
51
0.010
Why?
Cricetinae
1
2002
558
0.010
Why?
Collagenases
1
2001
41
0.010
Why?
Constriction
1
2001
27
0.010
Why?
Cell Cycle Proteins
1
2004
401
0.010
Why?
Cysteine Endopeptidases
1
2001
88
0.010
Why?
Mouth Mucosa
1
2001
67
0.010
Why?
Bleomycin
1
1981
102
0.010
Why?
Adenovirus E1B Proteins
1
2001
1
0.010
Why?
Isocoumarins
1
2000
7
0.010
Why?
Receptors, CCR5
1
2000
18
0.010
Why?
Radiation Tolerance
1
2002
173
0.010
Why?
Methotrexate
1
1981
250
0.010
Why?
Mitogen-Activated Protein Kinases
1
2002
226
0.010
Why?
Viremia
1
2001
49
0.010
Why?
Dose-Response Relationship, Radiation
1
2000
188
0.010
Why?
Receptors, CXCR4
1
2000
45
0.010
Why?
Laminin
1
2000
89
0.010
Why?
Glycosylation
1
2000
128
0.010
Why?
Mastectomy, Radical
1
2000
10
0.010
Why?
Drug Combinations
1
2000
202
0.010
Why?
Proteoglycans
1
2000
123
0.010
Why?
Structure-Activity Relationship
1
2000
412
0.010
Why?
Down-Regulation
1
2001
519
0.010
Why?
Molecular Sequence Data
2
1996
3027
0.010
Why?
Proteins
1
2005
786
0.010
Why?
Chi-Square Distribution
1
2000
360
0.010
Why?
Collagen
1
2000
293
0.010
Why?
Kinetics
2
1993
1528
0.010
Why?
Tegafur
1
1998
17
0.010
Why?
Uracil
1
1998
55
0.010
Why?
Amino Acid Sequence
2
1992
2062
0.010
Why?
Anticoagulants
1
2001
427
0.010
Why?
Software
1
2001
665
0.010
Why?
Nausea
1
1998
176
0.010
Why?
Environmental Pollution
1
1996
13
0.010
Why?
Genetic Variation
2
1993
1373
0.010
Why?
Polymorphism, Genetic
1
1999
825
0.010
Why?
Drug Tolerance
1
1995
64
0.010
Why?
Methylene Blue
1
1995
18
0.010
Why?
Actuarial Analysis
1
1994
66
0.010
Why?
Global Health
1
1996
186
0.010
Why?
CD4 Lymphocyte Count
1
1995
67
0.010
Why?
Methylprednisolone
1
1994
64
0.010
Why?
Food, Formulated
1
1994
24
0.010
Why?
Lymphocyte Count
1
1994
98
0.010
Why?
Burns, Chemical
1
1994
12
0.010
Why?
Nebulizers and Vaporizers
1
1995
56
0.010
Why?
Granuloma
1
1995
65
0.010
Why?
Esophageal Perforation
1
1994
18
0.010
Why?
Contraindications
1
1994
70
0.010
Why?
Nasal Mucosa
1
1995
191
0.010
Why?
Patient Care Planning
1
1995
83
0.010
Why?
Energy Intake
1
1994
97
0.010
Why?
Biopsy
1
1998
1183
0.010
Why?
Azathioprine
1
1994
124
0.010
Why?
Topotecan
1
1994
45
0.010
Why?
Binding, Competitive
1
1994
146
0.010
Why?
Cyclosporine
1
1994
237
0.010
Why?
Esophagus
1
1994
106
0.010
Why?
Antibody Specificity
1
1994
130
0.010
Why?
Retroviridae
1
1994
79
0.010
Why?
Clinical Protocols
1
1994
157
0.010
Why?
Gene Transfer Techniques
1
1994
153
0.010
Why?
Diet
1
1996
442
0.010
Why?
Chloramphenicol O-Acetyltransferase
1
1992
29
0.010
Why?
Bone Wires
1
1992
13
0.010
Why?
Achondroplasia
1
1992
8
0.010
Why?
Radioimmunoassay
1
1992
155
0.010
Why?
Immunoglobulin Idiotypes
1
1992
12
0.010
Why?
Antigen-Antibody Complex
1
1992
87
0.010
Why?
Immunoglobulin kappa-Chains
1
1992
96
0.010
Why?
Immunoglobulin Heavy Chains
1
1992
132
0.010
Why?
Cloning, Molecular
1
1993
646
0.010
Why?
Immunoglobulin Variable Region
1
1992
109
0.010
Why?
Radiation Dosage
1
1993
226
0.010
Why?
Genes, Immunoglobulin
1
1992
111
0.010
Why?
Neoplasms, Second Primary
1
1995
260
0.010
Why?
Syndactyly
1
1991
12
0.010
Why?
Philippines
1
1991
22
0.010
Why?
Antigens, Helminth
1
1991
22
0.010
Why?
Cross Reactions
1
1991
109
0.010
Why?
Gene Rearrangement
1
1992
172
0.010
Why?
Remission, Spontaneous
1
1991
53
0.010
Why?
HLA-DR Antigens
1
1991
59
0.010
Why?
Ovum
1
1991
59
0.010
Why?
Edema
1
1991
70
0.010
Why?
China
1
1991
233
0.010
Why?
Culture Techniques
1
1971
91
0.010
Why?
Fatty Acids, Nonesterified
1
1991
68
0.010
Why?
Herpesvirus 4, Human
1
1991
119
0.010
Why?
Liver Regeneration
1
1971
36
0.010
Why?
Liver Function Tests
1
1991
92
0.010
Why?
Aorta, Thoracic
1
1991
167
0.010
Why?
Transcription Factor TFIIA
1
1990
2
0.010
Why?
Transcription Factor TFIID
1
1990
3
0.010
Why?
Templates, Genetic
1
1990
34
0.010
Why?
Ischemia
1
1991
251
0.010
Why?
Protein Binding
1
1993
1487
0.010
Why?
Ultrasonography
1
1991
711
0.010
Why?
Temperature
1
1990
401
0.000
Why?
Intestines
1
1991
416
0.000
Why?
Neutropenia
1
1981
216
0.000
Why?
Vesicular stomatitis Indiana virus
1
1971
16
0.000
Why?
Hypophysectomy
1
1971
27
0.000
Why?
Thymidine
1
1971
59
0.000
Why?
Tritium
1
1971
133
0.000
Why?
Methods
1
1971
151
0.000
Why?
Bromodeoxyuridine
1
1971
58
0.000
Why?
Carbon Isotopes
1
1971
74
0.000
Why?
Haploidy
1
1971
32
0.000
Why?
Prolactin
1
1971
89
0.000
Why?
Growth Hormone
1
1971
96
0.000
Why?
Interferons
1
1971
124
0.000
Why?
Leiomyosarcoma
1
1971
45
0.000
Why?
Hybridization, Genetic
1
1971
106
0.000
Why?
Mammary Neoplasms, Experimental
1
1971
125
0.000
Why?
Testicular Neoplasms
1
1971
113
0.000
Why?
Thyroxine
1
1971
353
0.000
Why?
Selection, Genetic
1
1971
511
0.000
Why?
Insulin
1
1971
1146
0.000
Why?
Ovarian Neoplasms
1
1971
763
0.000
Why?
Posner's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (881)
Explore
_
Co-Authors (93)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_